Scientists from the Israel Institute of Technology, known as Technion, researched mice, through which they managed to develop diseases in the animal from a modification of its neurons. The finding allowed them to conclude that the human brain has the capacity to cause physical diseases, and therefore, these could also be cured through brain interventions.
The Israeli scientists reported that they have observed exactly how the brain can make the body sick and believe that by making certain adjustments in the behavior of the gray matter, they could stop inflammatory diseases in the intestine, colon, and elsewhere.
They arrived at their discovery after arduous studies in dozens of laboratory mice. By making specific changes in combinations of neurons in healthy mice, they could induce certain physical diseases.
The report says that the experiment seeks to demonstrate that some psychosomatic illnesses are caused by the brain replicating a physically induced illness episode in the body.
The study analysis process was; first, generate inflammation in the mouse colon and abdomen and from there perform a thorough analysis of the behavior of neurons.
Once recovered from the inflammation, the scientists activated the same neuronal combination in the animals and consequently noticed that inflammation developed in the same place as before.
“This suggests that the brain stores some kind of representation of inflammatory conditions that mice experience, and has a way of causing the same inflammation,” Professor Asya Rolls, a neuroimmunologist who led the study, told The Times Of Israel.
“I was surprised to see the effect so clearly, with inflammation starting soon after neurons were activated, even though there was no pathogen or other physical trigger,” added Rolls.
The successful professional was very optimistic about the research results, which have already been peer-reviewed and are rapidly being disseminated in specialized papers and journals.
It should be noted that there is a gap between the experiments on mice and what actually happens in humans. Still, it is irrefutable that this research opens a new line of investigation for psychosomatic diseases in people.
When studies can move from mice to humans, they will ultimately seek to pave the way for understanding the potentially psychosomatic elements of certain prevalent diseases such as irritable bowel syndrome and some allergies.
According to Rolls, this treatment approach could reduce reliance on immunosuppressants. This would be very important for the health of millions of people, considering that many inflammatory diseases are routinely treated with immunosuppressive drugs, which reduce the function of the immune system, making the patient more vulnerable to other pathologies due to their lowered defenses.